Close

Red Hat (RHT) volatility elevated; shares sell off on profit taking Dec 20, 2011 09:36AM
Citi Starts Red Hat (RHT) at Buy Aug 18, 2011 07:55AM
Daily State of the Markets 01/26: The Rotation Game Jan 26, 2011 08:58AM
Notable Analyst Rating Changes 12/07: UN, WTW, STP, RHT Upgraded; RIMM, NGD, INTC, FIRE Downgraded Dec 7, 2010 11:16AM
Goldman Sachs Upgrades NUAN, VMW to Buy; Downgrades ADSK, CVLT to Neutral; Lowers Price Targets in Software Jul 7, 2010 10:24AM


Nov 9, 2009 11:14AM Notable Analyst Rating Changes 11/09: RSH, ANF, NOC, ADBE, HERO Upgraded; RIMM, RHT, GPS, AZN, SGY Downgraded
Jun 25, 2009 10:06AM Notable Analyst Rating Changes 6/25: XRTX, DE, JCP, LM, SLM Upgraded; COP, RHT, HAL Downgraded
Jun 15, 2009 01:23PM Citi Sees Consolidation in Software Industry (INFA, OMTR, CTXS, RHT, more)
May 4, 2009 09:36AM David Moenning's Daily State of the Markets: 5/4
Mar 26, 2009 09:49AM Citi Maintains a 'Hold' on Red Hat (RHT); Relative Momentum Going into FY10; Tempting Acquisition Target
Mar 26, 2009 09:17AM Morning Movers 3/26: CTRN, CONN, BBY, GM, RHT, DPS Higher; UTIW, MFE, SNDA Lower
Mar 25, 2009 05:39PM After-Hours Movers 3/25: CTRN, DNR, CKR, OFC Higher; WX, AMKR Lower
Mar 24, 2009 02:22PM Trading Radar for 3/25: Solarfun (SOLF), Red Hat (RHT), Paychex (PAYX), PetroChina (PTR), DSW (DSW) Report; New Home Sales, Crude Inventories Due
Dec 23, 2008 09:42AM Citi Maintains a 'Hold' Rating on Red Hat (RHT) with a Hold, Lowers Price Target
Dec 23, 2008 09:26AM David Moenning's Daily State of the Markets: 12/23
Dec 23, 2008 09:01AM Wall Street Applauds "Solid" Results from Red Hat (RHT)
Dec 4, 2008 10:01AM Morning Movers 12/04: Merck (MRK) Lower On Guidance, Amazon.com (AMZN) Higher On Upgrade
Sep 25, 2008 09:32AM Pre-Open Movers 9/25: GE (GE) Lower On Profit Warning, Pilgrim's Pride (PPC) Sinks On Expected Large Loss and Covenant Triggers
Jun 26, 2008 10:08AM Notable Analyst Rating Changes 6/26: COCO, SOLF, PTRY Upgraded; GM, RHT, GS, MGM Downgraded
Mar 28, 2008 09:24AM Pre-Open Movers 3/28: JC Penney (JCP) Sinks on Lower Guidance, BioMimetic Therapeutics (BMTI) Higher After Addressing Concerns